Johnson & Johnson raises a flag in early-stage lung cancer with first-ever contest in the field

No question about it, the lung cancer field is hot—and chock-full of new drugs and combos. But there's a dearth of treatments specifically for early-stage disease, and Johnson & Johnson is looking to crowdsourcing to bring in new ideas.